2001

November

	Important Safety Information - EPREXTM (Epoetin Alfa) - Janssen-Ortho Inc. Date: 2001-11-26
	Important Safety Information Regarding AVANDIA® (Rosiglitazone Maleate) - GlaxoSmithKline Inc. Date: 2001-11-13
	Important Drug Safety Information - ACTOS (Pioglitazone Hydrochloride) - Eli Lilly Date: 2001-11-06

October

Important Drug Warning On RemicadeTM - Schering Canada Inc. Date: 2001-10-23

September

	Association of TOPAMAX* (Topiramate) with Acute Myopia and Secondary Angle Closure Glaucoma - Janssen-Ortho Inc. Date: 2001-09-13
	Important Safety Information Regarding Carnitor® - Sigma-tau Pharmaceuticals, Inc. Date: 2001-09-10
	Conditional Approval of Gleevec (IMATINIB) - Novartis Pharma Canada Inc. Date: 2001-09-01

August

	Recall of Specific Batches of Zirconia Ceramic Femoral Heads for Use in Hip Replacement Date: 2001-08-27
	Market withdrawal of Baycol (cerivastatin) - Bayer Inc. Date: 2001-08-08

July

	Cerivastatin (BAYCOL®) And Gemfibrozil - Increased Risk Of Rhabdomyolysis - Concomitant Use Contraindicated - Bayer Inc. Date: 2001-07-16
	Important Safety Information on Amiodarone Intravenous -Sabex Inc. Date: 2001-07-04
	Important Drug Warning - ZYBAN® - GlaxoSmithKline Date: 2001-07-03

June

	Update on Drug Products Containing Phenylpropanolamine (PPA) Date: 2001-06
	Important Safety Information on Nefazodone HCI: Severe and Serious Hepatic Events - Apotex Inc. Date: 2001-06-28
	Important Safety Notice - NEFAZODONE - Bristol-Myers Squibb and Linson Pharma Inc. Date: 2001-06-21
	Important Safety Information on HYDROVIEW IOL Lens - Bausch & Lomb Date: 2001-06-19

May

	Important Drug Warning - Lamisil - (terbinafine HCL) - Novartis Date: 2001-05-17
	Important Drug Warning - RITUXAN - Hoffmann-La Roche Ltd. Date: 2001-05-16
	Important Information-Camptosar - Pharmacia Date: 2001-05-11
	Important New Safety Information SPORANOX (itraconazole) - Janssen-Ortho Inc. Date: 2001-05-09
	Important Safety Information Severe and Serious Hepatic Reactions ARAVA - Aventis Pharma Inc. Date: 2001-05-04
	Important Safety Concerns re Use of Propofol for Sedation in Pediatric Patients - Health Products and Food Branch Notice to Hospitals Date: 2001-05-01

March

	Important Safety Information on ACCUTANE - Hoffman La Roche Limited, Canada Date: 2001-03-30
	Important Drug Warning : Hydrea (hydroxyurea) in Combination with Didanosine and/or Stavudine - Bristol-Myers Squibb Canada Inc. Date: 2001-03-28

February

	VIRAMUNE PEP - Health Products and Food Branch Notice to hospitals Date: 2001-02-26
	Important Safety Information - Propofol - Health Products and Food Branch Notice to hospitals Date: 2001-02-13

January

	Important Warnings from the Manufacturer Novartis on Drug Product Exelon - Novartis Date: 2001-01-26
	Important Drug Warning - VIDEX-ZERIT - Bristol-Myers Squibb Date: 2001-01-18
	Incidents Involving Patient Lifts - Health Products and Food Branch Date: 2001-01-01